Search results
You searched for:
Found 1,518 results
Sorting options:
Date: 01/01/2026 Location: Other
This medicinal cannabis course focuses on epilepsy in adults and children. The course studies the symptoms of Epilepsy 101, medicinal cannabis treatment options and modes of transmission. Several ways of application are outlined, as well as different products: artisanal preparations, unapproved products and approved medication of purified CBD. Dravet syndrome (DS) is explained, including treatment options, side effects and efficacy. A section describes Lennoz-Gastautsyndrome (LGS) and reviews research and treatment options including side effects. Tuberous Sclerosis Complex (TSC) symptoms are explained and studies and treatment options are discussed. Other potential applications of CBD are outlined including childhood epilepsy, next generation cannabis-based medicines, biosynthesis of cannabinoids in the plant and anticonvulsant effects.
4.5 Educational activity hours
6 Performance review hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
This medicinal cannabis course focuses on PTSD and treatment in clinical practice. The course assesses the use of medical cannabis for PTSD, including dosage and treatment. It describes what PTSD is and what the signs, symptoms and characteristics are. The conventional treatment of PTSD, e.g. sleeping medications or antidepressant medications, is being compared to the cannabinoid treatment options. The current position of the Department of Veterans Affairs (DVA) on PTSD is that compensation for PTSD treatment with medicinal cannabis is not allowed. However, research into medicinal cannabis is rapidly evolving and DVA will continue to monitor the developing research and published evidence. Two case studies look into symptoms, current medications, treatments using CBD, and provides reviews and results of these studies.
6 Performance review hours
Professionalism
Ethical practice
4 Educational activity hours
Date: 01/01/2026 Location: Other
This medicinal cannabis course focuses on advanced mental health conditions. The course commences with the importance of understanding the science of medicinal cannabis and the role it can play when treating mental health issues. Advantages and side effects are outlined. When managing complex mental health issues, the course describes treatment and techniques for schizophrenia, bipolar disorder, severe anxiety and depression. PTSD patients, often in military and first-responders frequently utilise medicinal cannabis. A comparison is made between THC-dominant (street cannabis), to CBD-dominant (hemp) or balanced (e.g. nabiximols). The course summarizes studies of the use of medicinal cannabis and mental disorders. The course also addresses the use of medicinal cannabis in conjunction with conventional medications, potential toxicities, most common symptoms treated and side-effects. Larger trials on the use of medicinal cannabis for treating mental health are in progress.
4 Educational activity hours
6 Performance review hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
This medicinal cannabis course focuses on cancer research for potential treatment with medical cannabis leading to a curative approach that goes beyond symptom relief. The course evaluates treatment options for breast and pancreatic cancer patients with medical cannabis and evaluates the use of medical cannabis to mitigate the side effects of cancer and its treatment. It looks into early diagnosis, treatment, defining and aetiology of cancer as well as defining and targeting the hallmarks of cancer. Clinical and side-effects of CBD and Δ9-Tetrahydrocannabinol (THC) are listed. Outcomes of studies into cannabinoids in pain management and palliative medicine are included.
4 Educational activity hours
6 Performance review hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
This medicinal cannabis course focuses on complex chronic diseases. Content includes planning the management of complex chronic diseases including poly pharmacy, multiple system disease. It evaluates the challenges of effectively integrating cannabis medicines including liver metabolism considerations and drug interactions. The results of a study into patients with chronic diseases (conditions that last 1 year or more and require ongoing medical attention, long lasting conditions with persistent effects), are included where patients have at least two conditions and were prescribed a minimum of four drugs. When choosing a cannabis product, the preferences of the patient, age and clinical condition are to be considered. The course describes dosing of THC and CBD and minimum/ maximum doses. A case study looks into current medications, past treatments, clinical history, treatment options, progress and life quality.
4 Educational activity hours
6 Performance review hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
This medicinal cannabis course focuses on endocannabinoid support – advanced techniques for maximising ECS efficiency. The course evaluates clinical endocannabinoid deficiency (CED) and examines options to maximise the efficiency and function of the endocannabinoid system including diet, supplements terpenes and therapies. Migraine, fibromyalgia, IBS and related conditions display common clinical, biochemical and pathophysiological patterns that suggest an underlying clinical endocannabinoid deficiency that may be suitably treated with cannabinoid medicines. This course discusses findings that provide a mechanistic scenario for how chronic stress, diet and gut microbiota generate a pathological feed-forward loop that contributes to despair behaviour via the central ECS. Finally, a case study of a patient with a long history of migraine headaches, insomnia and anxiety is described, looking at past treatments and treatment options.
4.5 Educational activity hours
6 Performance review hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
This course looks at the planning of clinical treatment and dosing for conditions with medicinal cannabis. General rules of dosing with cannabis medicines are given noting that doses of cannabis medicines should be administered with consistency and regularity. Minimal doses that are clinically effective should be a principle aim. Patient age and previous cannabis use/ experience must be taken into consideration. Cannabis medications should be titrated slowly and conventional medications reduced as symptoms lessen. Treating of rheumatoid arthritis, neuropathic pain, fibromyalgia, headaches and migraine, multiple sclerosis, Parkinson’s (tremor and dystonia), Chron’s disease and ulcerative colitis, chemotherapy induced nausea and vomiting, anxiety and depression, insomnia, PTSD, epilepsy, ASD, ADHD, OCD and Tourette's, diabetes, hypertension, glaucoma, geriatric/palliative care and complex mental health issues are reviewed in this course.
4.5 Educational activity hours
6 Performance review hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
This Women’s Health course focusses on cognitive and sleep issues in perimenopause and menopause and obstructive sleep apnoea. It then moves to recurrent urinary tract infections after menopause including cystitis and genitourinary syndrome of menopause. The final topic includes comprehensive information on hidradenitis suppurativa (acne inversa). Overviews of each condition, the causes, screening, clinical features, differential diagnoses and management options are presented. Case studies are presented for each focus area. andlt;grammarly-desktop-integration data-grammarly-shadow-root="true"andgt;andlt;/grammarly-desktop-integrationandgt;
5 Educational activity hours
5 Performance review hours
Professionalism
Ethical practice
5 MOPS (AST - Adult Internal Medicine) hours
Date: 01/01/2026 Location: Other
This clinical audit is designed for medical practitioners to build on the knowledge gained from previous studies of medicinal cannabis use for chronic pain.The audit provides the opportunity to review and analyse previous clinical management of patients with chronic pain, develop a plan to educate and increase skills and knowledge in this area and implement this plan. Participants will apply their medicinal cannabis learning to treating patients with chronic pain with medicinal cannabis, demonstrating increased skills and knowledge in their management of patient cases. The audit includes a critical case analysis of each case. This stage will be peer reviewed. This audit together with the Complex Certificate of Medicinal Cannabis courses combine to be the HealthCert Professional Diploma of Medicinal Cannabis.
19.5 Outcome measurement hours
2 Performance review hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
This clinical audit is designed for medical practitioners to build on the knowledge gained from previous studies of medicinal cannabis for neurological disorders. The audit provides the opportunity to review and analyse previous clinical management of patients with neurological disorders, develop a plan to educate and increase skills and knowledge in this area and implement this plan. Participants will apply their medicinal cannabis learning to treating patients with neurological disorders with medicinal cannabis, demonstrating increased skills and knowledge in their management of patient cases. The audit includes a critical case analysis of each case. This stage will be peer reviewed. This audit together with the Complex Certificate of Medicinal Cannabis courses combine to be the HealthCert Professional Diploma of Medicinal Cannabis.
2 Performance review hours
19.5 Outcome measurement hours
Professionalism
Ethical practice